register

ESG

New Leukaemia Foundation CEO steps up the fight for a blood cancer-free future

Health Industry Hub | January 29, 2021 |

The Leukaemia Foundation has launched into 2021 with renewed energy, experience and passion at the helm, as newly-appointed Chief Executive Officer Chris Tanti commences leading the organisation from Monday 1 February 2021.

An accomplished CEO in Australia and America, Mr Tanti began his career in social work and, for the past 25 years, has held national and international senior executive positions, including CEO of Australia’s National Disability Services and leading mental health organisation, Headspace.

Mr Tanti holds qualifications from La Trobe and Melbourne Universities, in addition to Harvard Business School, and has dedicated his career to health services advocacy and organisational innovation.

Leukaemia Foundation Chairman Dr Carrie Hillyard AM said the organisation was thrilled to have a professional of Mr Tanti’s calibre steering the Leukaemia Foundation into its 46th year and beyond.

“Chris’ career is characterised by the creation of game-changing health services, in addition to extensive experience in strategy, service delivery and operational management. Most importantly, Chris has a genuine resolve to change healthcare for the better and he is dedicated to improving lives and delivering lasting impact for the communities he works to serve,” she said.

“This combination means Chris brings the perfect skillset to head Australia’s leading blood cancer charity and the experience to drive progress to help Australians conquer their blood cancer. As a new decade begins, we look forward to Chris being an enthusiastic leader of both the Leukaemia Foundation and the broader blood cancer community.”

Mr Tanti said he was proud to take up position as a strong voice for all Australians living with blood cancer, no matter where they live or what their diagnosis.

“You only have to mention leukaemia, lymphoma or myeloma and you’ll soon come across someone who’s faced blood cancer themselves, or who knows and loves someone who’s been diagnosed. The sheer number of Australians impacted by this complex set of diseases is staggering, and sadly that number is continuing to rise at an extraordinary rate,” he said.

“While the blood cancer journey has improved for many, there is much work to do to improve this journey for all, and I am ready to join the passionate Leukaemia Foundation team and the wider blood cancer community to do that work – to fix our sights firmly on a future free from blood cancer and drive life-saving outcomes together.

“I am inspired by the Leukaemia Foundation’s vision and the critical role it plays in the lives of patients and families every day, and excited to lead an organisation that aligns with my values and energy to create positive, lasting change for vulnerable Australians.

“The Leukaemia Foundation is the only national charity dedicated to helping Australians with blood cancer and related disorders to survive and live their best life after diagnosis. We will create better access to treatment, care, support and information for every family facing blood cancer around Australia, wherever they are across the country, and by uniting with the broader blood cancer community, we will realise our shared vision of zero lives lost to blood cancer by 2035.

“Our goals are bold and ambitious, but they must be. We can’t stand idly by while blood cancer continues to take so many lives. It is time to turn the tables on blood cancer, and I am proud today to begin leading the organisation championing that change at a national level.”


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


News & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer

AI-powered test to reshape use of hormone therapy in prostate cancer

Health Industry Hub | February 6, 2025 |

Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]

More


News & Trends - MedTech & Diagnostics

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Health Industry Hub | February 6, 2025 |

Vantive, formerly Baxter’s Kidney Care business, has officially launched as a standalone company. The move follows Baxter’s completion of the […]

More


News & Trends - MedTech & Diagnostics

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Health Industry Hub | February 6, 2025 |

An Australian medical technology company has introduced a test designed to identify obstructive sleep apnoea (OSA), broadening access to sleep […]

More


This content is copyright protected. Please subscribe to gain access.